RNA interference and HIV-1 infection

Reviews in Medical Virology

Volumn 18, Issue 1, 2008, Pages 5-18

  Kanzaki, Luis Isamu Barros ^a   Ornelas, Socrates Souza ^a   Argañaraz, Enrique R ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLESTEROL DERIVATIVE; DOUBLE STRANDED RNA; GAG PROTEIN; INITIATION FACTOR 2ALPHA; INTERFERON; INTERFERON REGULATORY FACTOR; LENTIVIRUS VECTOR; MICRORNA; NEF PROTEIN; POL PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE; REPEAT ASSOCIATED SMALL INTERFERING RNA; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SMALL INTERFERING RNA CHOLESTEROL CONJUGATE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

3' UNTRANSLATED REGION; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; ENVELOPE GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENOME ANALYSIS; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PLANT GENETICS; REVIEW; RNA INTERFERENCE; STRUCTURAL GENE; UNTRANSLATED REGION; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE;

GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; HIV INFECTIONS; HIV-1; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; VIRUS LATENCY; VIRUS REPLICATION;

EID: 38549087901     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.553     Document Type: Review

References (145)

1. Cohen OJ, Fauci AS. Current strategies in the treatment of HIV infection. Adv Intern Med 2001; 46: 207-246.
2. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 1998; 95(15): 8869-8873.
3. Willey R, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology 1992; 66(12): 7193-7200.
4. Weiss R. How does HIV cause AIDS? Science 1993; 260(5112): 1273-1279.
5. Buchbinder SP, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 inffection without immunologic progression. AIDS 1994; 8(8): 1123-1128.
6. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296(5572): 1439-1443.
7. O'Connor DH, Allen TM, Vogel TU, et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002; 8(5): 493-499.
8. de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13(3): 367-371.
9. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418(6898): 646-650.
10. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427(6977): 848-853.
11. Varthakavi V, Smith RM, Bour SP, Strebel K, Spearman P. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci USA 2003; 100(25): 15154-15159.
12. Marban C, Suzanne S, Dequiedt F, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. Embo J 2007; 26(2): 412-423.
13. Roulet V, Satie AP, Ruffault A, et al. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol 2006; 169(6): 2094-2103.
14. Bagasra O. A unified concept of HIV latency. Expert Opin Biol Ther 2006; 6(11): 1135-1149.
15. Fire A, Xu S, Montgomery MK, Kostas AS, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669): 744-745.
16. Ketting RF, Haverkamp TH, van Luenen HG, Plasterk RH. Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 1999; 99(2): 133-141.
17. Yang N, Kazazian HH Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 2006; 13(9): 763-771.
18. Vance V, Vaucheret H. RNA silencing in plants-defense and counterdefense. Science 2001; 292(5525): 2277-2280.
19. Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against viruses. Nature 2001; 411(6839): 834-842.
20. Ambros V. The functions of animal microRNAs. Nature 2004; 431(7006): 350-355.
21. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-297.
22. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75(5): 843-854.
23. Lim LP, Lau NC, Weinstein EG, et al. The microRNAs of Caenorhabditis elegans. Genes Dev 2003; 17(8): 991-1008.
24. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science 2004; 304(5671): 734-736.
25. Omoto S, Fujii YR. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol 2005; 86(Pt 3): 751-755.
26. Bennasser, Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005; 22(5): 607-619.
27. Pfeffer S, Sewer A, Lagos-Quintana M, et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005; 2(4): 269-276.
28. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005; 435(7042): 682-686.
29. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. Host-virus interaction: a new role for microRNAs. Retrovirology 2006; 3: 68.
30. Weinberg MS, Morris KV. Are viral-encoded micro-RNAs mediating latent HIV-1 infection? DNA Cell Biol 2006; 25(4): 223-231.
31. Lecellier CH, Dunoyer P, Arar K, et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308(5721): 557-560.
32. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309(5740): 1577-1581.
33. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315(5818): 1579-1582.
34. Vagin VV, Sigova A, Li C, Seitz H, Gvozdev V, Zamore PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science 2006; 313(5785): 320-324.
35. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411(6836): 494-498.
36. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418(6896): 435-438.
37. Novina CD, Murray MF, Dykxhoorn DM, et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8(7): 681-686.
38. Brisibe EA, Okada N, Mizukami H, Okuyama H, Fujii YR. RNA interference: potentials for the prevention of HIV infections and the challenges ahead. Trends Biotechnol 2003; 21(7): 306-311.
39. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75(5): 855-862.
40. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294(5543): 858-862.
41. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294(5543): 862-864.
42. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853-858.
43. van der Krol AR, Mur LA, Beld M, Mol JN, Stuitje AR. Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell 1990; 2(4): 291-299.
44. Napoli C, Lemieux C, Jorgensen R. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell 1990; 2(4): 279-289.
45. Tomari Y, Zamore PD. Perspective: machines for RNAi. Genes Dev 2005; 19(5): 517-529.
46. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15(2): 188-200.
47. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16(8): 948-958.
48. Paddison PJ, Hannon GJ. RNA interference: the new somatic cell genetics? Cancer Cell 2002; 2(1): 17-23.
49. Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002; 12(15): 1301-1311.
50. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296(5567): 550-553.
51. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA 2002; 99(3): 1443-1448.
52. Han J, Kori R, Shui JW, Chen YR, Yao Z, Tan TH. The SH3 domain-containing adaptor HIP-55 mediates c-Jun N-terminal kinase activation in T cell receptor signaling. J Biol Chem 2003; 278(52): 52195-52202.
53. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA 2004; 101(7): 1927-1932.
54. Siolas D, Lerner C, Burchard J, et al. Synthetic shRNAs as potent RNAi triggers. Nat Biotechnol 2005; 23(2): 227-231.
55. Lee MT, Coburn GA, McClure MO, Cullen BR. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat-or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003; 77(22): 11964-11972.
56. Anderson J, Akkina R. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005; 2(1): 1.
57. Brown AE, Catteruccia F. Toward silencing the burden of malaria: progress and prospects for RNAi-based approaches. Biotechniques 2006; Suppl: 38-44.
58. Fritz JH, Girardin SE, Philpott DJ. Innate immune defense through RNA interference. Sci STKE 2006; 2006(339): pe27.
59. Simmons KJ, Nde PN, Kleshchenko YY, Lima MF, Villalta F. Stable RNA interference of host thrombospondin-1 blocks Trypanosoma cruzi infection. FEBS Lett 2006; 580(9): 2365-2370.
60. Tong AW. Small RNAs and non-small cell lung cancer. Curr Mol Med 2006; 6(3): 339-349.
61. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001; 8(2): 113-126.
62. Williams BR. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans 1997; 25(2): 509-513.
63. Maitra RK, McMillan NA, Desai S, et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 1994; 204(2): 823-827.
64. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425(6956): 415-419.
65. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. Embo J 2002; 21(17): 4663-4670.
66. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary micro-RNA processing. Genes Dev 2004; 18(24): 3016-3027.
67. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432(7014): 231-235.
68. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004; 14(23): 2162-2167.
69. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17(24): 3011-3016.
70. Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286(5441): 950-952.
71. Parrish S, Fleenor J, Xu S, Mello C, Fire A. Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell 2000; 6(5): 1077-1087.
72. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404(6775): 293-296.
73. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436(7051): 740-744.
74. Haase AD, Jaskiewicz L, Zhang H, et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep 2005; 6(10): 961-967.
75. Jiang F, Ye X, Liu X, Fincher L, McKearin D, Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev 2005; 19(14): 1674-1679.
76. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. Embo J 2006; 25(3): 522-532.
77. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409(6818): 363-366.
78. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293(5532): 1146-1150.
79. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004; 305(5688): 1289-1292.
80. Buhler M, Mohn F, Stalder L, Muhlemann O. Transcriptional silencing of nonsense codon-containing immunoglobulin minigenes. Mol Cell 2005; 18(3): 307-317.
81. Castanotto D, Tommasi S, Li M, et al. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther 2005; 12(1): 179-183.
82. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304(5670): 594-596.
83. Chiu YL, Rana TM. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol Cell 2002; 10(3): 549-561.
84. Saunders LR, Barber GN. The dsRNA binding protein family: critical roles, diverse cellular functions. Faseb J 2003; 17(9): 961-983.
85. Aravin A, Gaidatzis D, Pfeffer S, et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006; 442(7099): 203-207.
86. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14(10A): 1902-1910.
87. John B, Enright AJ, Aravin A, Tuschi T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004; 2(11): e363.
88. Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 2003; 278(45): 44312-44319.
89. Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003; 100(17): 9779-9784.
90. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433(7027): 769-773.
91. Giraldez AJ, Mishima Y, Rihel J, et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 2006; 312(5770): 75-79.
92. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 2006; 103(11): 4034-4039.
93. Hariharan M, Scaria V, Pillai B, Brahmachari SK. Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 2005; 337(4): 1214-1218.
94. Bennasser Y, Le ST, Yeung ML, Jeang KT. HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 2004; 1(1): 43.
95. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, Jeang KT. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2005; 2: 81.
96. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000; 18: 665-708.
97. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002; 53: 557-593.
98. Morris KV. siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code. Cell Mol Life Sci 2005; 62(24): 3057-3066.
99. Dorin D, Bonnet MC, Bannwarth S, Gatignol A, Meurs EF, Vaquero C. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J Biol Chem 2003; 278(7): 4440-4448.
100. Daher A, Longuet M, Dorin D, et al. Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem 2001; 276(36): 33899-33905.
101. Endo-Munoz L, Warby T, Harrich D, McMillan NA. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol J 2005; 2: 17.
102. Cai R, Carpick B, Chun RF, Jeang KT, Willians BR. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 2000; 373(2): 361-367.
103. Ong CL, Thorpe JC, Gorry PR, et al. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol 2005; 79(20): 12763-12772.
104. Christensen HS, Daher A, Soye KJ, et al. Small Interfering RNAs against the TAR RNA Binding Protein, TRBP, a Dicer Cofactor, Inhibit Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression and Viral Production. J Virol 2007; 81(10): 5121-5131.
105. Li MJ, Bauer G, Michienzi A, et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003; 8(2): 196-206.
106. Zhang Z, Burke JM. Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity. J Virol 2005; 79(6): 3728-3736.
107. Morris KV, Rossi JJ. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Hum Gene Ther 2006; 17(5): 479-486.
108. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002; 76(18): 9225-9231.
109. Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther 2003; 10(24): 2046-2050.
110. Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004; 32(3): 1154-1158.
111. Das AT, Brummelkamp TR, Westerhout EM, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004; 78(5): 2601-2605.
112. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003; 77(21): 11531-11535.
113. Banerjea A, Li MJ, Bauer G, et al. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003; 8(1): 62-71.
114. Schwab R, Ossowski S, Riester M, Warthmann N, Weigel D. Highly specific gene silencing by artificial microRNAs in Arabidopsis. Plant Cell 2006; 18(5): 1121-1133.
115. Akashi H, Miyagishi M, Yokota T, et al. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol Biosyst 2005; 1(5-6): 382-390.
116. Yamamoto T, Omoto S, Mizuguchi M, et al. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol 2002; 46(11): 809-817.
117. Konstantinova P, de Vries W, ter Brake O, Haasnoot J, de Haan P, Berkhout B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther 2006; 13(19): 1403-1413.
118. Nishitsuji H, Kohara M, Kannagi M, Masuda T. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J Virol 2006; 80(15): 7658-7666.
119. Konstantinova P, ter Brake O, Haasnoot J, de Haan P, Berkhout B. Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome. Retrovirology 2007; 4: 15.
120. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 1993; 177(6): 1561-1566.
121. Lama J, Mangasarian A, Trono D. Cell-surface expression of CD4 reduces HIV-1infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 1999; 9(12): 622-631.
122. Cortes MJ, Wong-Staal F, Lama J. Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J Biol Chem 2002; 277(3): 1770-1779.
123. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr HIV Res 2003; 1(2): 167-184.
124. Levesque K, Finzi A, Binette J, Cohen EA. Role of CD4 receptor down-regulation during HPV-1 infection. Curr HIV Res 2004; 2(1): 51-59.
125. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. Embo J 1997; 16(23): 6964-6976.
126. Piguet V, Chen YL, Mangasarian A, Foti M, Carpentier JL, Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. Embo J 1998; 17(9): 2472-2481.
127. Bresnahan PA, Yonemoto W, Greene WC. Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for downregulation of CD4. J Immunol 1999; 163(6): 2977-2981.
128. Craig HM, Reddy TR, Riggs NL, Dao PP, Guatelli JC. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1,2, and 3: role of the dileucine-based sorting motif. Virology 2000; 271(1): 9-17.
129. Piguet V, Gu F, Foti M, et al. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 1999; 97(1): 63-73.
130. Cohen GB, Rangan VS, Chen BK, Smith S, Baltimore D. The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation. J Biol Chem 2000; 275(30): 23097-23105.
131. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 1998; 8(5): 647-656.
132. Liu LX, Margottin F, Le Gall S, et al. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. J Biol Chem 1997; 272(21): 13779-13785.
133. Watanabe H, Shiratori T, Shoji H, et al. A novel acylCoA thioesterase enhances its enzymatic activity by direct binding with HPV Nef. Biochem Biophys Res Commun 1997; 238(1): 234-239.
134. Stevens TH, Forgac M. Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol 1997; 13: 779-808.
135. Geyer M, Yu H, Mandic R, et al. Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J Biol Chem 2002; 277(32): 28521-28529.
136. Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol Rev 1999; 168: 51-63.
137. Piguet V, Trono D. The Nef protein of primate lentiviruses. Rev Med Virol 1999; 9(2): 111-120.
138. Kestler HW III, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991; 65(4): 651-662.
139. Iafrate AJ, Carl S, Bronson S, et al. Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J Virol 2000; 74(21): 9836-9844.
140. Carl S, Greenough TC, Krumbiegel M, et al. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 2001; 75(8): 3657-3665.
141. Tobiume M, Takahoko M, Yamada T, Tatsumi M, Iwamoto A, Matsuda M. Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. J Virol 2002; 76(12): 5959-5965.
142. Pham HM, Arganaraz ER, Groschel B, Trono D, Lama J. Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes. J Virol 2004; 78(23): 13072-13081.
143. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004; 431(7006): 371-378.
144. Reich SJ, Fosnot J, Kuroki A, et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003; 9: 210-216.
145. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432(7014): 173-178.